Niagen®

DIETARY_SUPPLEMENT2 trials

Sponsors

University of Delaware, Nutraceuticals Research Institute

Conditions

Healthy AgingMild Cognitive Impairment

Phase 1

NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment

CompletedNCT03482167

University of DelawareMild Cognitive Impairment

Start: 2019-03-20End: 2024-01-22Updated: 2025-04-04

Unknown Phase

Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+

RecruitingNCT06919328

Nutraceuticals Research InstituteHealthy Aging

Start: 2024-10-31End: 2025-06-30Target: 70Updated: 2025-04-09